CARDLYTICS INC's ticker is CDLX and the CUSIP is 14161W105. A total of 140 filers reported holding CARDLYTICS INC in Q2 2022. The put-call ratio across all filers is 0.95 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,646 | +161.1% | 524 | 0.0% | 0.00% | – |
| Q2 2023 | $3,312 | +86.2% | 524 | 0.0% | 0.00% | – |
| Q1 2023 | $1,779 | -41.3% | 524 | 0.0% | 0.00% | – |
| Q4 2022 | $3,029 | -49.5% | 524 | -19.9% | 0.00% | – |
| Q3 2022 | $6,000 | -53.8% | 654 | +13.1% | 0.00% | – |
| Q2 2022 | $13,000 | -55.2% | 578 | +8.2% | 0.00% | -100.0% |
| Q1 2022 | $29,000 | -17.1% | 534 | +1.5% | 0.00% | 0.0% |
| Q4 2021 | $35,000 | -18.6% | 526 | +1.7% | 0.00% | 0.0% |
| Q3 2021 | $43,000 | -35.8% | 517 | -1.7% | 0.00% | -66.7% |
| Q2 2021 | $67,000 | +31.4% | 526 | +12.2% | 0.00% | +50.0% |
| Q1 2021 | $51,000 | -23.9% | 469 | 0.0% | 0.00% | -33.3% |
| Q4 2020 | $67,000 | +28.8% | 469 | -35.9% | 0.00% | 0.0% |
| Q3 2020 | $52,000 | +2.0% | 732 | +0.7% | 0.00% | 0.0% |
| Q2 2020 | $51,000 | +121.7% | 727 | +10.2% | 0.00% | +50.0% |
| Q1 2020 | $23,000 | – | 660 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners VIII LLC | 1,133,141 | $29,439,000 | 58.62% |
| Polaris Venture Management Co. V, L.L.C. | 2,277,342 | $59,165,000 | 46.48% |
| CAS Investment Partners, LLC | 2,162,020 | $56,169,000 | 14.39% |
| Cannell Capital | 626,975 | $16,289,000 | 4.62% |
| Antipodean Advisors LLC | 142,358 | $3,698,000 | 4.50% |
| Shannon River Fund Management LLC | 344,230 | $8,943,000 | 1.42% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 19,048 | $495,000 | 1.40% |
| Tygh Capital Management, Inc. | 176,237 | $4,579,000 | 0.78% |
| Penn Capital Management Company, LLC | 263,499 | $6,846,000 | 0.68% |
| EAM Global Investors LLC | 56,866 | $1,477,000 | 0.63% |